Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHZE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,595
Award facts
- Contract value 100% obligated
- $11,595.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,595.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The contract contains no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Defense Logistics Agency acquisition strategy designed to ensure reliable pharmaceutical supply chains for military healthcare facilities worldwide. DMS Pharmaceutical Group's prime vendor contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized and diverse pharmaceutical requirements of the federal military medical system with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DU26FEHZE?
SPE2DU26FEHZE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FEHZE worth?
The government has obligated $11,595 on SPE2DU26FEHZE.
Is contract SPE2DU26FEHZE an order under another contract?
Yes. SPE2DU26FEHZE is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZE competed?
The extent of competition for SPE2DU26FEHZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award